- Year: 2022
- October 23, 2002
Medicamen Lifesciences Begins Operations, Expands Pharmaceutical Manufacturing
Medicamen Lifesciences, a subsidiary of MEDICAMEN BIOTECH, officially launched operations in 2022. The company specializes in the manufacturing and marketing of pharmaceutical products, with a focus on Anti-hypertensives, Antidiabetics, and Cardiology treatments.
Recent Posts
Shivalik Rasayan API Facility at Dahej (Gujarat) is now USFDA Approved
November 16, 2024
